Quantinuum (QNT) Registration filing summary

Company overview and business model

• Operates a vertically integrated, full-stack quantum computing platform combining hardware, middleware, and application software for hybrid quantum-classical workflows.

• Focuses on high-fidelity trapped-ion quantum systems using QCCD architecture, with proprietary and open-source developer tools.

• Monetizes through hardware access (on-premises and cloud), software licensing, research/application development services, and outcome-oriented IP.

• Formed in 2021 via the combination of Honeywell Quantum Solutions and Cambridge Quantum; Honeywell remains a major shareholder and strategic partner.

• Serves global enterprise, government, and research customers in sectors like pharmaceuticals, materials science, finance, and cybersecurity.

Financial performance and metrics

• Net revenue for the year ended December 31, 2025: $30.9 million; net loss: $192.6 million.

• Net revenue for the three months ended March 31, 2026: $5.2 million; net loss: $136.6 million.

• Cash and cash equivalents as of March 31, 2026: $677.0 million.

• Adjusted EBITDA for the year ended December 31, 2025: $(171.2) million.

• Revenue is concentrated, with a few large customers accounting for a significant portion; bookings for 2025 totaled $79.3 million.

Use of proceeds and capital allocation

• Net proceeds of approximately $1.36 billion (assuming $54.00/share IPO price) will be used to purchase newly issued Common Units from Quantinuum Holdings.

• Quantinuum Holdings will use proceeds for general corporate purposes and to pay offering expenses.

• A portion of proceeds may be used for potential acquisitions or investments in complementary technologies or businesses.